Drug-Induced Acute Kidney Injury (Aki): A Patternbased Clinical Approach

The condition of drug induced acute kidney injury (AKI) serves as a major yet obviously preventable reason for kidney damage which affects patients receiving hospital treatment or those in critical condition. The condition exhibits a swift decrease in glomerular filtration rate which shows up as increased serum creatinine levels or decreased urine production. Drugs account for almost 20 percent of AKI cases which occur in general hospital wards while their presence in intensive care units reaches 30 percent thus showing the critical need for doctors to identify these cases at their initial stages. The article introduces a clinical pattern-based framework for drug-induced acute kidney injury which links renal pathophysiological processes with hospital diagnostic methods. The process of injury shows three main pathways which include two types of hemodynamic damages and one type of intrinsic renal damage and one postrenal damage. The use of NSAIDs and ACE inhibitors and ARBs and diuretics results in hemodynamic AKI through disturbances to the body's natural ability to regulate blood flow to the kidneys. Nephrotoxic drugs such as aminoglycosides and vancomycin and amphotericin B and cisplatin cause acute tubular injury which constitutes intrinsic renal damage while β-lactam antibiotics and proton pump inhibitors lead to immune-mediated acute interstitial nephritis. Postrenal injuries can develop through two main pathways which include crystal nephropathy development and drug-induced urinary retention. The diagnostic method uses a structured framework which combines drug exposure timelines with clinical patterns and laboratory results and imaging studies.